Expression of human telomerase reverse transcriptase in vulvar intraepithelial neoplasia and squamous cell carcinoma, An immunohistochemical study with survivin and p53

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 11, 2012, Pages 1359-1365

  Wellenhofer, Alfred ^a   Brustmann, Hermann ^a  

^a Landesklinikum Thermenregion Baden ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN P53; TELOMERASE; TERT PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CARCINOMA IN SITU; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; VULVA TUMOR;

APOPTOSIS; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53; VULVAR LICHEN SCLEROSUS; VULVAR NEOPLASMS;

EID: 84870881640     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0440-OA     Document Type: Article

References (30)

1. Logani S. Vulvar neoplasia/squamous neoplasia. In: Nucci MR, Oliva E, eds. Gynecologic Pathology. 1st ed. London, England: Elsevier Churchill Livingstone; 2009:41-60.
2. Kyo S, Masutomi K, Maida Y, et al. Significance of immunological detection of human telomerase reverse transcriptase. Am J Pathol. 2003;163(3):859-867.
3. Bonatz G, Frahm SO, Klapper W, et al. High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus. Hum Pathol. 2001;32(6):605-614.
4. Altieri DC. Survivin and IAP proteins in cell death mechanisms. Biochem J. 2010;430(2):199-205.
5. Li F, Yang J, Ramnath N, Javle MM, Tan D. Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer. 2005;114(4):509- 512.
6. Brustmann H, Hinterholzer S, Brunner A. Immunohistochemical expression of survivin and g-H2AX in vulvar intraepithelial neoplasia and low stage squamous cell carcinoma. Int J Gynecol Pathol. 2011;30(6):583-590.
7. Altieri D: Validating survivin as a cancer therapeutic target. Nat Rev Cancer. 2003;3(1):46-54.
8. Brustmann H, Naudé S. Expression of topoisomerase IIa, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. Gynecol Oncol. 2002;86(2):192-199.
9. Hacker N. Revised FIGO staging for carcinoma of the vulva. Int J Gynecol Obstet. 2009;105(2):105-106.
10. Wynford-Thomas D. Cellular senescence and cancer. J Pathol. 1999; 187(1):100-111.
11. Shay JW. Telomerase in cancer: diagnostic, prognostic, and therapeutic implications. Cancer J Sci Am. 1998;4(suppl 1):S26-S34.
12. Wada H, Enomoto T, Yoshino K, et al. Immunohistochemical localization of telomerase hTERT protein and analysis of clonality in multifocal vulvar intraepithelial neoplasia. Am J Clin Pathol. 2000;114(3):371-379.
13. Saha B, Chaiwun B, Tsao-Wei DD, et al. Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions. Int J Gynecol Pathol. 2007;26(3):214-222.
14. Lo Muzio L, Pannone G, Staibano S, et al. Survivin expression in oral squamous cell carcinoma. Br J Cancer. 2003;89(12):2244-2248.
15. Branca M, Giorgi C, Santini D, et al. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol. 2005;124(1): 113-121.
16. Liu X, Gao R, Dong Y, et al. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition. BMC Cancer. 2010;10:418.
17. Shan SJ, Zhang N, Geng SL, et al. Expression of survivin and human telomerase reverse transcriptase in extramammary Paget's disease. J Cutan Pathol. 2010;37(6):635-640.
18. Karanikas V, Tsochas S, Boukas K, et al. Co-expression patterns of tumorassociated antigen genes by non-small cell lung carcinomas: implications for immunotherapy. Cancer Biol Ther. 2008;7(3):345-352.
19. Yuan J, Yang BM, Zhong ZH, et al. Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase. Oncogene. 2009;28(29):2678-2689.
20. Furuya M, Tsuji N, Kobayashi D, Watanabe N. Interaction between survivin and aurora-B kinase plays an important role in survivin-mediated upregulation of human telomerase reverse transcriptase expression. Int J Oncol. 2009;34(4):1061-1068.
21. Endoh T, Tsuji N, Asanuma K, Yagihashi A, Watanabe N. Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c- Myc-mediated human telomerase reverse transcriptase gene transcription. Exp Cell Res. 2005;305(2):300-311.
22. Zhang W, Tong Q, Wu O, Li S, Wang X, Wang Q. Upregulated p27kip1 can downregulate survivin expression and inhibit telomerase activity in gastric carcinoma cells. Cancer Invest. 2009;27(9):898-900.
23. Barbosa LC, da Silva ID, Correa JC, Ribalta JC. Survivin and telomerase expression in the uterine cervix of women with human papillomavirus-induced lesions. Int J Gynecol Cancer. 2011;21(1):15-21.
24. Lam AK, Saleh S, Smith RA, Ho YH. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity. Hum Pathol. 2008;39(8):1229-1233.
25. Kunze D, Wuttig D, Kausch I, et al. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo. Int J Oncol 2008;32(5):1049-1056.
26. Wang R, Lin F, Wang X, et al. The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression. Cancer Biol Ther 2007;6(8):1295-1301.
27. van der Avoort IA, van de Nieuwenhof HP, Otte-Holler I, et al. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva. Hum Pathol. 2010;41(10):1475-1485.
28. Chiesa-Vottero A, Dvoretsky PM, Hart WR. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am J Surg Pathol. 2006;30(3):310-318.
29. Pinto AP, Miron A, Yassin Y, et al. Differentiated vulvar intraepithelial neoplasia contains TP53 mutations and is genetically linked to vulvar squamous cell carcinoma. Mod Pathol. 2010;23(3):404-412.
30. Leonhardt DT, Einenkel J, Sohr S, et al. p53 signature and serous tubal insitu carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Int J Gynecol Pathol. 2011;30(5):414-424.